Skip to main content
. 2021 Jun 9;12:664010. doi: 10.3389/fneur.2021.664010

Table 1.

Baseline characteristics including levels of GDF-15 in ICH cases and controls.

All Controls Cases P value
n 464 244 220
Age (year, mean ± SD) 62 ± 7 62 ± 7 62 ± 7 0.88
Men [n (%)] 224 (48) 119 (49) 105 (48) 0.82
Systolic blood pressure (mmHg, mean ± SD) 149 ± 21 146 ± 21 153 ± 20 0.0012
Diastolic blood pressure (mmHg, mean ± SD) 88 ± 11 87 ± 11 90 ± 11 0.0028
Blood pressure medication [n (%)] 111 (24) 55 (23) 56 (25) 0.46
Body mass index (kg/m2, mean ± SD) 25.9 ± 17.9 25.8 ± 3.9 26.0 ± 4.2 0.56
Diabetes mellitus [n (%)] 28 (6.0) 14 (5.7) 14 (6.4) 0.78
Smoking [n (%)] 119 (26) 49 (20) 70 (32) 0.004
High alcohol consumption* [n (%)] 20 (4.3) 6 (2.5) 14 (6.4) 0.039
Use of warfarin [n (%)] 10 (2.2) 2 (0.8) 8 (3.6) 0.037
GDF-15+, mean ± SD (log2 transformed) 8.07 (0.78) 7.94 (0.77) 8.20 (0.77) 0.0003
GDF-15+ (median interquartile range) 263 (176–370) 236 (165–399) 298 (205–417) 0.0001**

GDF, growth differentiation factor 15.

*

>40 g/day for men and >30 g/day for women.

+

Normalized protein expression (NPX) values.

P-values for cases vs. controls were calculated using ANOVA or Pearson χ2.

**

Mann-Whitney U test used due to skewed distribution of GDF15 values.